Introduction
The aging-associated increase of many cancer types has been linked with stromal fibroblast senescence and concomitant production of diffusible growth factors, cytokines, and extracellular matrix/ remodeling proteins (1) that are similarly induced in cancer-associated fibroblasts (CAFs) (2) . However, fully established CAFs show no signs of senescence and are often characterized by increased cell proliferation (3, 4) , consistent with a multistep process of CAF activation associated with cancer/stromal cell expansion (5) .
Alterations of key regulators of transcription and chromatin organization involved in early steps of CAF activation include downmodulation of CSL/RBP-Jκ (subsequently called CSL), the key effector of Notch signaling endowed with intrinsic transcriptional-repressive function and overall determinant of chromatin configuration (5, 6) . CSL functions as a direct negative regulator of many CAF effector genes and at the same time binds to p53, suppressing its activity (5) . As a consequence, decreased CSL levels in stromal fibroblasts result in the concomitant induction of CAF effector genes and p53-dependent cellular senescence, with decreased p53 expression and activity occurring as a second step leading to full CAF activation (5) .
The impact of hormonal signaling on CAF activation has been scarcely studied. Among hormones, androgens play an important role in both males and females as determinants of systemic functions such as metabolism and immune system (7, 8) . In addition, they have a significant impact on tissue processes such as angiogenesis (9) , muscle strength, wound healing, and brain activity (10) (11) (12) . The role of androgens in prostate cancer is well documented (13) , and there is emerging evidence that they are also implicated in female tumors, specifically breast cancer (14) .
The androgen receptor (AR) has highly context-dependent functions (15) . Surprisingly few studies have focused on its role in CAFs, so far limited to prostate cancer with apparently conflicting conclusions (16) (17) (18) (19) (20) (21) . In a mouse model, loss of stromal AR was reported to limit prostate cancer lesions, while, in human tumors, lower stromal AR expression was associated with a lower degree of cancer cell differentiation and poor prognosis (18) .
Like AR, the biological functions of Notch/CSL signaling are highly context dependent (22) . So far, only an indirect interplay between AR and Notch signaling has been reported in cellular systems unrelated to CAF activation (23, 24) . Here we show that, in dermal fibroblasts, AR and CSL physically converge on negative control of key senescence and CAF effector genes. These findings are of functional and clinical significance, as stromal AR expression is coordinately downmodulated with CSL at premalignant stages of cancer development (actinic keratoses, dysplastic nevi), and, in an orthotopic model, decreased AR expression in dermal fibroblasts promotes tumorigenicity of both skin squamous cell
The aging-associated increase of cancer risk is linked with stromal fibroblast senescence and concomitant cancer-associated fibroblast (CAF) activation. Surprisingly little is known about the role of androgen receptor (AR) signaling in this context. We have found downmodulated AR expression in dermal fibroblasts underlying premalignant skin cancer lesions (actinic keratoses and dysplastic nevi) as well as in CAFs from the 3 major skin cancer types, squamous cell carcinomas (SCCs), basal cell carcinomas, and melanomas. Functionally, decreased AR expression in primary human dermal fibroblasts (HDFs) from multiple individuals induced early steps of CAF activation, and in an orthotopic skin cancer model, AR loss in HDFs enhanced tumorigenicity of SCC and melanoma cells. Forming a complex, AR converged with CSL/RBP-Jκ in transcriptional repression of key CAF effector genes. AR and CSL were positive determinants of each other's expression, with BET inhibitors, which counteract the effects of decreased CSL, restoring AR expression and activity in CAFs. Increased AR expression in these cells overcame the consequences of CSL loss and was by itself sufficient to block the growth and tumor-enhancing effects of CAFs on neighboring cancer cells. As such, the findings establish AR as a target for stroma-focused cancer chemoprevention and treatment.
Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation op frequently in photo-aged skin (25) . To assess possible cancer field effects on stromal AR expression, we examined relatively large excisions of two AK lesions and surrounding flanking skin, quantifying immunofluorescence AR signal intensity in dermal fibroblasts within several topographically delimited areas at various distances from the lesions. As shown in Figure 1A and Supplemental Figure 1A (supplemental material available online with this article; https://doi.org/10.1172/JCI99159DS1), we found consistently decreasing AR levels in dermal fibroblasts underneath the lesions as compared with those further away. A similar approach was adopted for "topographical quantification" of AR levels in stromal fibroblasts underlying 2 dysplastic nevi versus skin furcarcinoma and melanoma cells. Conversely, increased AR expression in CAFs overcomes the consequences of CSL loss and suppresses the growth/tumor-promoting effects that these cells have on neighboring cancer cells. As such, AR is a novel potential target for stroma-focused cancer chemoprevention and treatment.
Results
Decreased AR expression triggers early steps of CAF activation. The skin provides a benchmark for studies on the interplay between stromal changes and early steps of cancer development. The role of AR signaling in this context is largely unknown. Actinic keratoses (AKs) and dysplastic nevi are precancerous lesions that devel- To assess the functional significance of these findings, we evaluated the consequences of AR knockdown. Silencing of the gene in several HDF strains resulted in increased expression of α-smooth muscle actin (αSMA), a well-established marker of CAF activation (Supplemental Figure 2C) , which was paralleled by induction of a battery of CAF effector genes ( Figure 4, A and B) . Induction of such genes occurred also upon AR gene silencing in lung fibroblasts and in pancreatic stellate cells (Supplemental Figure 3, A and B) .
Paralleling the above findings, treatment of several HDF strains with flutamide, a nonsteroidal antagonist that competes with androgens for AR binding and activation (26) , also induced expression of CAF effector genes ( Figure 4C ), which were instead suppressed by treatment with AR agonists such as dihydrotestosterone (DHT) or MK-2866 (SARM) ( Figure 4D and Supplemental Figure 3C ). No suppressing effects were observed in CAFs even after prolonged DHT treatment for 3 or 7 days, consistent with the low AR levels present in these cells (Supplemental Figure 3 , D and E).
Early steps of CAF activation and stromal fibroblast senescence are closely intertwined events. As upon CSL knockdown (5), AR silencing in multiple HDF strains resulted in reduced proliferation and increased senescence ( Figure 5, A and B) . This was parther away. Even in these cases, there was a progressive decrease in AR expression in stromal fibroblasts underlying the lesions versus those in areas further away ( Figure 1B and Supplemental Figure 1B) . Diminished AR expression in lesion-adjacent fibroblasts was confirmed by analysis of additional AK and dysplastic nevus samples (with a calculation of the statistical significance of the observed differences for all lesions; Figure 2 , A and B), as well as of several skin squamous cell carcinomas (SCCs) and basal cell carcinomas (BCCs) relative to cancer-free skin of the same patients excised at the end of the surgical procedure ("dog ears") ( Figure  2 , C and D, and Supplemental Figure 1C ). This analysis could not be extended to invasive melanoma lesions because of overlapping melanocyte and fibroblast markers hampering unequivocal cell identification in tissue sections. Diminished AR expression was further confirmed at the mRNA level, by fluorescence-guided laser capture microdissection (LCM) and quantitative reverse transcriptase PCR (RT-qPCR) analysis of SCC-associated stromal fibroblasts, in which CAF markers like IL6 (interleukin-6) and POSTN (periostin) were also increased, versus dog-ears fibroblasts of the same patients ( Figure 2E ).
Decreased AR level was also observed by immunoblot analysis of multiple strains of human dermal fibroblasts (HDFs) versus CAFs derived from SCCs, BCCs, or melanomas ( Figure 3, A-D) . Differences in AR expression were also confirmed at the cellular Increased p53 expression by AR silencing is of functional significance, as silencing of the gene overcame the growth-suppressing effects of AR knockdown ( Figure 6D ). Molecularly, induction of CDKN1A was abrogated by concomitant AR and TP53 silencing, while the upregulation of the IL6 CAF effector gene occurred to an extent similar to or greater than that seen in controls ( Figure 6E ), consistent with previous findings that p53 functions as a transcriptional repressor of CAF effector genes (5, 27) . Thus, downmodulation of AR expression or activity is sufficient to trigger early steps of CAF activation, with concomitant induction of CAF effector genes and p53-dependent cellular senescence.
alleled by strong suppression of p105-Rb phosphorylation (Ser780 and Ser795), decreased levels of phospho-H3 and PCNA, and downmodulation of the MKI67 and c-MYC proliferation marker genes, while gene expression of cyclin-dependent kinase inhibitors (CDKN1A and CDKN2B) was induced ( Figure 5 , C and D).
Together with the above changes, p53 expression was enhanced in HDFs with silenced AR at both protein and mRNA levels ( Figure  6 , A and B). Chromatin immunoprecipitation (ChIP) assays with 3 different HDF strains showed AR binding to 2 consensus-binding sites present in the TP53 gene promoter and proximal regulatory region, pointing to p53 as a direct negative AR target ( Figure 6C ). AR and CSL converge on negative control of CAF activation. AR controls transcription in both a positive and a negative manner (15) . By RNA-Seq analysis, we found a consistent up-and downregulation of several hundred genes in 2 different HDF strains with AR silencing versus controls (Supplemental Table 1 ). Gene ontology analysis showed that upregulated genes were significantly enriched for functions related to extracellular matrix, wounding, and immune and inflammatory responses, while downregulated genes were enriched for nuclear functions related to nucleosome organization, transcription, and other nuclear and RNA biosynthetic processes (Supplemental Figure 7A and Supplemental Table 1) .
Gene set enrichment analysis (GSEA) allows an unbiased comparison of gene expression profiles with previously established gene signatures (29) . Using this approach, we found a significant association between the profile of upregulated genes in HDFs with AR knockdown and a signature of CAF effector genes as well as a more extended signature of CSL gene silencing, a critical repressor of CAF activation (refs. 5, 6 and Supplemental Figure 7B ). In keeping with this finding, the profile of upregulated genes in HDFs with AR knockdown was also significantly associated with other signatures of relevance to CAF activation under CSL control in HDFs (ref. 5 and Supplemental Table 2 ).
TGF-β signaling is a key pathway leading to CAF activation in multiple organs/compartments (2) . Besides CAF effectors, direct comparison of RNA-Seq profiles of HDFs with AR versus CSL silencing pointed to the TGFBR1 gene as a common AR and CSL target. RT-qPCR and immunoblot analysis confirmed that TGFBR1 expression is induced in HDFs upon AR and CSL silencing and showed that it is also upregulated in CAFs (Supplemental Figure 8, A-D) . TGFBR1 levels were also increased in dermal fibroblasts underlying SCC and AK lesions, by LCM/RT-qPCR analysis and immunofluorescence, respectively (Supplemental Figure 8 , E and F).
The above results raised the possibility that AR and CSL converge on transcriptional control of CAF activation. We found that the promoter and upstream regulatory regions of various CAF effector genes such as IL6, POSTN, PLOD2, FAP, and TGFBR1 harbor a clustering of predicted AR and CSL binding sequences ( Figure 9 , A and B; Supplemental Figure 8G ; and Supplemental Figure 9A ). ChIP assays of multiple HDF strains cultured in charcoal-stripped medium (to remove serum-bound testosterone) with or without DHT treatment showed ligand-dependent binding of AR to the predicted sites ( Figure 9 , A and B; Supplemental Figure  8G ; and Supplemental Figure 9A ). In parallel, we found increased activated histone marks at these sites in HDFs with AR silencing (Supplemental Figure 9B ) and in CAFs compared with matched HDFs (Supplemental Figure 9C) . Further ChIP and re-ChIP assays, based on sequential immunoprecipitation with antibodies against CSL and AR, showed parallel binding of the AR and CSL proteins to many of these sites with concomitant binding to some of them ( Figure 9C and Supplemental Figure 8H ). Such close and concomitant binding of AR and CSL to common sites suggested that the 2 proteins can be part of the same complex. In fact, an AR-CSL association could be easily visualized by proximity ligation assays (PLAs), using HDFs with silenced CSL as specificity control ( Figure 10A ). Similar assays were repeated with HDFs cultured in medium with charcoal-treated serum, and with or without DHT treatment, showing that AR-CSL association is ligand dependent ( Figure 10B ). Consistent with their decreased AR and CSL levels, the number of PLA-positive puncta was markedly reduced in a set of CAFs when compared with matched normal skin HDFs derived from the same patients (Supplemental Figure 10A ).
Coimmunoprecipitation experiments with antibodies against either AR or CSL followed by reciprocal immunoblotting confirmed association of the 2 endogenous proteins in HDFs ( Figure 10C ). In addition, 2 long noncoding RNAs (lncRNAs) involved in control of chromatin organization that directly interact with AR, HOTAIR and SRA (steroid receptor RNA activator) (30, 31) , were also found to associate with CSL, while no association was found with an unrelated lncRNA, H19, or GAPDH mRNA control ( Figure 10D) .
Thus, AR converges with CSL in negative control of CAF effector genes as part of the same complex.
Concordant downmodulation of AR and CSL in CAFs and counteracting impact of BET inhibitors and AR overexpression.
Robust biological systems depend on coordinated control of key network elements. Parallel downmodulation of AR and CSL in dermal fibroblasts underlying premalignant and malignant skin cancer lesions and various CAFs raised the possibility of a reciprocal cross-regulation. Immunoblot and RT-qPCR analysis showed consistent suppression of AR expression, at both mRNA and pro- we previously reported in HDF with decreased CSL levels (6). In fact, ChIP analysis of HDFs with CSL gene silencing versus controls showed an increase of the repressive histone mark H3K9Me3 and a decrease of the active histone mark H3K27Ac at the AR protein levels, in multiple HDF strains with CSL knockdown ( Figure  11 , A and B). As CSL functions as a repressor of transcription, the concomitant downmodulation of AR expression is likely to occur through an indirect mechanism and epigenetic changes like those impact of chromatin modifications on the basal transcription complex (6) . GSEA analysis of the gene expression profiles of several CAF strains treated with JQ1 showed a suppression of the AR gene silencing signature (Supplemental Figure 11A) . Underlying these changes, we found that treatment of CAF as well as HDF strains with JQ1 and 2 other BET inhibitors (iBET-762 and OTX-015) under clinical trials (32) induced AR expression at both the mRNA and protein levels (Figure 12 , A-C, and Supplemental Figure 11 , B-D). We previously reported that topical treatment with JQ1 in the mouse ear orthotopic model suppresses CAF activation and SCC cell expansion (6) . Similar assays with SK-MEL-23 melanoma cells admixed with CAFs showed even more pronounced effects of JQ1 treatment, with strong suppression of tumor growth that made moter region, with reduced POLII recruitment and a decrease of the elongation histone mark H3K36Me in the transcribed gene body region ( Figure 11C ).
An attractive possibility was also that AR expression in turn controls CSL expression. In fact, combined immunoblot and RT-qPCR analysis showed that in multiple HDF strains AR gene silencing caused a consistent downmodulation of CSL expression only at the protein level, without any effects on the mRNA (Figure 11, D and E) .
Further studies on joint control of AR and CSL expression will have to be separately pursued. Here we focused on the possible translational implications of the findings for reversion of the CAF phenotype. The global effects of CSL loss on CAF activation are counteracted by treatment with BET protein inhibitors that interfere with the was also unaffected or even induced by AR overexpression ( Figure  13 , A and B), indicating that increased AR levels can suppress CAF effector genes, short-circuiting the consequences of CSL loss. In parallel with the above results, AR overexpression suppressed the ability of CAFs to enhance proliferation and stem cell potential of neighboring SCC13 cancer cells, as assessed by conventional cocultures and 3D sphere-forming assays, respectively ( Figure 13, C and D) . Even in vivo, tumorigenic expansion of SCC13 cells was significantly decreased when they were admixed with AR-overexpressing CAFs in comparison with controls ( Figure 14A ). This was accompanied by a lower proliferative index of cancer cells and enhanced squamous differentiation with reduced CAF marker expression, angiogenesis, and macrophage infiltration (Figure 14 , B-F, and Supplemental Figure 12 , B and C). it difficult to obtain tissue sections of the JQ1-treated lesions for analysis ( Figure 12D ). Importantly, JQ1 treatment of SK-MEL-23 cells in vitro did not significantly affect their growth (Supplemental Figure 11 , E and F), pointing to the importance of the impact of this compound on tumor-stromal cell interaction.
To assess whether increased AR expression is by itself sufficient to reproduce the BET inhibitor impact on CAFs, we infected these cells with an AR-overexpressing lentivirus. Increased AR expression resulted in the consistent suppression of multiple CAF effector genes that are induced by AR and CSL loss ( Figure 13 , A and B, and Supplemental Figure 12A ). Importantly, downmodulation of these genes by increased AR levels occurred in the absence of CSL upregulation, which was rather suppressed. Concomitantly, expression of the HES1 gene, a negative CSL target in fibroblasts and CAFs (5), We focused on skin cancer, as a benchmark of major clinical significance for cancer development. We found that AR levels are downmodulated in CAFs derived from all 3 major skin cancer types, SCC, BCC, and melanoma, and are already reduced in stromal fibroblasts underlying premalignant AK and dysplastic nevus lesions. Decreased AR expression is of functional importance as it is sufficient to trigger dermal fibroblasts to CAF activation, with consequent enhancement, in an orthotopic model of both SCC and melanoma tumor expansion.
The AR protein can act as either repressor or activator of gene transcription, depending on cell type, target genes, and proteins with which it associates (15) . Loss of AR expression in multiple independent HDF strains, from both male and female donors, led to induction of key CAF effector genes, with a similar induction in fibroblasts from other body sites, indicating that AR is likely to play a general repressive function in CAF activaThus, AR is coordinately controlled with CSL, and its upregulation is of translational significance for suppression of CAF activation and stroma-focused anticancer intervention.
Discussion
Conversion of stromal fibroblasts into CAFs is likely to occur as a multistep process with concomitant deregulation of several pathways (2, 5, 6, 33) . Surprisingly, the impact of hormone signaling in this context has been explored to a very limited extent (7) . AR is functionally involved in various aspects of cell and tissue homeostasis in organs with both reproductive and nonreproductive functions (15) . Levels of androgens decline with age (34), suggesting that decreased AR signaling contributes to various aspects of the aging process, including tissue atrophy and impaired metabolic functions (34, 35) . Whether decreased AR signaling is also a determinant of cancer risk remains to be established. The functional involvement of AR loss in early steps of CAF activation is strikingly similar to that of CSL. Reduction of both AR and CSL expression leads to p53-dependent cellular senescence. Mechanistically, while CSL inhibits p53 activity through direct binding (5), AR suppresses p53 expression, with p53 as direct negative target. AR and CSL converge also on negative control of CAF effector genes, binding concomitantly to neighboring sites. Physical association of the 2 proteins, as detected by proximity ligation and coimmunoprecipitation assays, suggests that they are part of a common transcription-repressive complex, which is ligand dependent. In support of this possibility, HOTAIR and SRA, 2 regulatory lncRNAs that interact with AR (30, 31) , were found to associate also with CSL.
AR and CSL are concomitantly reduced at early steps of CAF activation. Parallel downmodulation of the two can be reinforced by the reciprocal regulatory loop that we have uncovered, whereby silencing of one gene resulted in suppression of the other. As CSL functions as a repressor of gene transcription, concomitant downmodulation of AR must occur through an indirect mechanism tion. Paralleling the genetic findings, treatment of normal fibroblasts with flutamide, a selective antagonist that competes with androgens for AR binding and activation (26) , resulted in induction of CAF effector genes, while expression of these genes was suppressed by AR agonists.
While androgen signaling promotes differentiation in normal prostate tissue (36) , androgen deprivation therapy (ADT) is the mainstay treatment of metastatic prostate cancer (26) . Even in this context, however, inhibition of AR signaling has been reported to promote rather than suppress malignant progression of prostate cancer cells (37) and prostate cancer relapse through an impact on T cell activation (38) , a concern that may extend to cancer stromal fibroblasts. In this context, we also note a reported association between melanoma incidence and previous history of prostate cancer, even if it was not determined whether prostate cancer patients were subjected to ADT (39, 40) . In addition, a positive correlation between ADT of prostate cancer patients and subsequently increased incidence of colorectal cancer was reported (41, 42). AR expression was sufficient to short-circuit CSL loss and suppress CAF tumor-enhancing properties. AR is a highly studied target of pharmacological intervention (43, 44) , and compounds leading to its increased expression and/or activity open new possibilities for stroma-focused cancer prevention and treatment.
Methods
Cell culture, cell manipulations, and treatments. HDFs, CAFs, and SCC13, CAL27, 293T, SK-MEL-28, and SK-MEL-23 cells were maintained in DMEM (Thermo Fisher Scientific) supplemented with 10% (vol/vol) FBS (Thermo Fisher Scientific) and 1% penicillin/streptomyincluding reported changes in other transcription factors and/or chromatin configuration (6) . AR silencing resulted in decreased CSL expression only at the protein level, pointing to an impact on post-transcriptional control of this protein, through scarcely understood mechanisms that need to be further investigated. Emerging evidence indicates that CAF activation is the result of an epigenetic process amenable to pharmacological intervention. In this context, treatment with BET inhibitors, which counteract the global gene expression changes caused by compromised CSL function in CAFs (6), restored AR expression in these cells. The findings are of likely translational significance, as increased with a lentiviral expression vector for constitutive expression of AR, a gift of Karl-Henning Kalland (Bergen University, Bergen, Norway), in parallel with LacZ as control. RNAi experiments were carried out using shRNA-targeting lentiviral vectors from MilliporeSigma (for CSL, AR), as previously described (5) . The details of the vectors used for RNAi are given in Supplemental Table 3 . For drug treatment 24 hours after seeding, HDFs or CAFs were treated with 100 nM JQ1 (Adooq Biosciences) or DMSO as control, or 10 μM MK-2866 (Selleckchem) or EtOH as control, for 24 hours before lysis. Flutamide (1 μM) treatment (Santa Cruz Biotechnology), or EtOH as control, was carried out for 48 hours before lysis. For testosterone treatments, HDFs or CAFs were washed 4 times in PBS after seeding and left 48 hours in phenol red-free DMEM complemented with hormone-stripped FBS (Thermo Fisher Scientific) before treatment with 20 nM DHT (MilliporeSigma) for 24 hours for HDFs and for 3 or 7 days for CAFs. SK-MEL-23 melanoma cells were treated with 100 nM JQ1 (Adooq Biosciences) or DMSO for 24 hours for 5-ethynyl-2′-deoxyuridine (EdU) assay.
cin. Conditions of HDF and CAF isolation were previously reported (33) . Human pancreatic stellate cells were maintained in stellate cell medium supplemented with 2% (vol/vol) FBS, 1% penicillin/streptomycin, and 1% stellate growth supplement (ScienCell). All cells were grown at 37°C in the humidified incubator (Thermo Fisher Scientific) with 5% CO 2 . Cell lines were routinely tested to exclude mycoplasma contamination. Information regarding HDF strains and cell lines is reported in Supplemental Tables 4 and 5 .
Skin SCC13 cells were originally reported in ref. 45 , and CAL27 were originally provided by Genrich Tolstonog (University Hospital of Lausanne, Lausanne, Switzerland). For in vivo approaches, SCC13 and CAL27 cells were infected with an EGFP-expressing lentivirus (5), while SK-MEL-23 cells were concomitantly infected with RFP-and GFP-expressing fluorescence ubiquitination cell cycle indicator (FUC-CI) viruses (28) . HDF and CAF strains were stably infected with a lentiviral expression vector for constitutive expression of Myc-tagged CSL in parallel with empty vector control. CAF strains were infected ChIP tagmentation (ChIPmentation) (47) and qPCR analysis were carried out using anti-AR antibodies (Santa Cruz Biotechnology) versus nonimmune IgGs, starting from 15 × 10 6 HDFs. The immunoprecipitation of the sonicated chromatin was carried out using a previously described protocol (6) . The bead-bound chromatin was tagged with
Gene expression studies, LCM, ChIP, ChIPmentation, and re-ChIP studies. Gene expression and conditions of LCM studies were carried out as previously described (5, 33) .
ChIP assay for histone modification of H3K27Ac, H3K9Me3, H3K36Me, and POLII was carried out as previously described (46) . [Roche]). The lysate was precleared by centrifugation, and the supernatant was incubated with anti-CSL antibodies (Cell Signaling) or nonimmune IgGs overnight at 4°C. RNA-protein complexes were captured with antibody-coupled protein A magnetic beads, washed with RIP buffer, and treated with RNase-free DNase I. RNAs were isolated using the Trizol method. Approximately 200 ng of RNA from both immunoprecipitation and mock (nonimmune IgG) pull-down was converted to cDNA using random hexamer primer. The RT-qPCR was carried out with lncRNA-specific primers, and fold enrichment was calculated against mock. Tumorigenesis experiments. Mouse intradermal tumorigenicity ear injection assays were carried out in 8-to 10-week-old female NOD. Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice (The Jackson Laboratory), as in ref. Data and software availability. Data sets generated for this study were deposited in the NCBI Gene Expression Omnibus (GEO) public repository (GSE107319, "Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq]").
Statistics. Data are presented as mean ± SEM or mean ± SD, as indicated in the legends. For qPCR gene expression assays, histograms represent the value of each single strain. For gene expression and functional testing assays, statistical significance of differences between experimental groups and controls was assessed by 2-tailed unpaired or paired t test or by 1-way ANOVA with Dunnett's test to correct for multiple comparisons, as indicated in the figure legends. A P value less than 0.05 was considered as statistically significant. For each experiment, at least 3 separate HDF strains were used in the independent experiments. For ChIP-re-ChIP experiments, because of the complexity of the setting, the experiment was carried out in 1 strain. For ChIP assay regarding the AR histone modifications of AR promoter, 2 strains were used.
For ear injection/tumorigenicity assays, the individual animal variability issue was minimized by contralateral ear injections of the same animals with control versus experimental combinations of cells. No statistical method was used to predetermine sample size in animal experiments. No exclusion criteria were adopted for studies and sample collection. No randomization was used, and the researchers were not blinded.
Study approval. HDFs were prepared from discarded human skin samples from abdominoplasty or circumcision at the Department of Surgery or Pediatrics, Lausanne University, with required institutional approvals (UNIL: CER-VD 222/12) and informed consent. Matched normal human skin samples and samples of SCCs were obtained at the Department of Dermatology, Massachusetts General Hospital, as discarded parts not needed for diagnosis. All samples were processed as approved by the institutional review board (MGH: 2000P002418) and as described in refs. 5, 33. Matched normal skin and AK sections were provided by the Department of Dermatology, University of Tubingen, with institutional review board approvals and informed consent, as previously reported in ref. 5 . Dysplastic nevus skin sections were obtained from the Department of Dermatology, University Hospital Zürich, with institutional review board approvals and informed consent. Experiments on human-derived material followed the principles of the Declaration of Helsinki as well as the Swiss laws governing human research.
Tn5 transposase (Nextera DNA Sample Prep kit, Illumina) (47) . The "tagmented" chromatin was de-cross-linked and subjected to proteinase K digestion. Equal amounts of recovered DNA (5 ng) were subjected to amplification with tag-specific primers (14 cycles). Tag-specific PCR products were diluted (1:10), and 1 μl was used as a template for qPCR to determine the enrichment of the indicated sites; the primer sequences are listed in Supplemental Table 3 .
For re-ChIP assays, bead-bound chromatin samples, recovered after immunoprecipitation with either anti-CSL or nonimmune IgGs, were subjected to tagmentation and eluted in 2% SDS, 15 mM DTT in 1× TE buffer. Eluted products were diluted in immunoprecipitation buffer (Tris-HCl, pH 8.0, 1 mM EDTA, 150 mM NaCl, 0.1% Triton X-100, 1 mM PMSF, 1× protease inhibitors) and subjected to a second round of ChIP (re-ChIP) with anti-AR antibodies. After washing, the bead-bound chromatin fragments were de-cross-linked and eluted using proteinase K digestion. The eluted DNAs were amplified and subjected to ChIP-qP-CR with specific primers (Supplemental Table 3 ) as described above. The enrichment (log 2 -fold) in ChIP or re-ChIP over nonimmune IgGs is indicated as relative chromatin binding. Regulatory regions in the IL6, POSTN, PLOD2, FAP, TGFBR1, TP53, and AR genes were identified by loading of available track information for H3K4Me3 (for promoter) and H3K4Me1 (for enhancer elements) from data deposited in the Encyclopedia of DNA Elements at UCSC (ENCODE) for adult HDFs using the University of California, Santa Cruz (UCSC) Genome Browser (https:// genome.ucsc.edu/encode/). Putative AR and CSL binding sites in the regulatory regions of the TP53, IL6, POSTN, PLOD2, FAP, and TGFBR1 genes were predicted using Matinspector (Genomatix).
Cell and coculture assays, immunoblots, and immunofluorescence. Immunoblots and immunofluorescence analyses were performed as previously described (5, 33) . For 2D coculture assays, SCC13 and fibroblast cells were mixed (1:1 ratio) in complete DMEM containing 10 % Matrigel (BD Biosciences) and plated onto 8-chamber glass slides (Corning). The cells were allowed to grow for 4 days in regular culture conditions. At the end of the experiment, the medium was removed from the glass slides, adherent cells were fixed with 4% paraformaldehyde and washed with PBS, and immunofluorescence staining was carried out with anti-vimentin (for fibroblasts) and anti-pan-keratin (for SCC13) antibodies. The slides were imaged using a Zeiss LSM880 confocal microscope with a ×20 objective. The images were processed in ZEN Black software, and the number of large SCC13 cell clusters (>40 cells) was counted per field manually.
For 3D coculture assays, the SCC13 and fibroblast cells were mixed and plated onto 8-well chamber slides precoated with Matrigel (BD Biosciences). In brief, 8-well chambers were coated with 100 μl Matrigel per well and incubated for 30 minutes to polymerize at 37°C. The SCC13 cells and the fibroblasts were mixed at a 1:1 ratio in complete DMEM with 1% Matrigel and overlaid on polymerized Matrigel chambers. The spheroids were allowed to grow for 6 days and analyzed using an EVOS Cell Imaging System (Thermo Fisher Scientific). The diameter of the spheroids was measured using ImageJ (NIH). See complete unedited blots for Figures 3-6 , 10-13, and Supplemental Figures 3, 8 , and 11 in the supplemental material.
RNA immunoprecipitation. RNA immunoprecipitation (RIP) assay was carried out as described in ref. 48 with minor modifications. Briefly, HDFs were lysed in RIP buffer (10 mM Tris-HCl, pH 7.5, 0.5% Nonidet P-40, 150 mM NaCl, 2 mM MgCl 2 , 1 mM DTT, 0.1 mM EDTA, 10% glycerol, 100 U/ml RNase inhibitor, and 1× protease inhibitor cocktail jci.org Volume 128 Number 12 December 2018
performed the bioinformatics analysis. ML, PK, RD, and VN provided clinical samples. AC, SG, and GPD designed the study and wrote the manuscript.
